Bilge Ogut
Bilge Ogut resigned from the Board, including any committees thereof, effective immediately.
Highest-materiality recent filing
Concentrix Q2 revenue $2.46B (+1.9% YoY); GAAP EPS $0.86, non-GAAP EPS $2.63, record cash flow
Revenue $2,462.5M (+1.9% YoY as reported; +0.6% constant currency).
Concentrix Q1 revenue up 5.4% but GAAP EPS drops 68% to $0.33, margins shrink
Revenue $2,500.4M (+5.4% YoY); operating income $118.6M (-29.8%); GAAP EPS $0.33 (-68.3%).
Concentrix reports Q4 GAAP loss of $23.85/sh on $1.5B goodwill impairment; FY rev +2.2%
Q4 revenue $2,552.9M (+4.3% YoY); FY revenue $9,825.8M (+2.2% YoY).
Concentrix Q3 revenue above guidance; raises full-year growth outlook, increases dividend
Revenue $2,483M (+4.0% YoY), above guidance; constant-currency growth 2.6%.
Revenue $2,417M (+1.5% YoY) beat guidance; full-year growth outlook raised.
New unsecured facilities: $750M 3-year term loan, $250M 3-year delayed draw, $500M 5-year delayed draw, and $1.1B revolver; $750M converted to Continued Term Loan maturing Dec 2026.
Concentrix beats Q1 guidance; revenue $2.37B, non-GAAP EPS $2.79
Revenue $2,372M (-1.3% YoY); constant-currency growth +1.3%.
Concentrix Q4 rev $2.45B (+9.7% YoY); GAAP EPS $1.72; buyback auth raised to $600M
Q4 revenue $2,448M (+9.7% YoY); FY2024 revenue $9,619M (+35.2% YoY, includes acquisitions).
Concentrix Q3 revenue $2.39B beats guidance; raises dividend 10%
Revenue $2,387.4M, +46.2% YoY; pro forma const cur rev growth 2.6%. GAAP EPS $0.25, Non-GAAP EPS $2.87 +4% YoY.
Concentrix Q2 revenue $2.38B (+47% YoY), beats expectations; raises FY2024 revenue guidance
Revenue $2,380.7M, up 47.4% YoY; GAAP EPS $0.98 (down 35%), non-GAAP EPS $2.69 (up 2.3%).
Concentrix increases receivables securitization facility to $600M and extends to April 2026
Commitment raised from $500M to $600M; termination extended from July 2024 to April 2026.
Concentrix Q1 revenue $2.4B (+46.8% YoY), GAAP EPS $0.76 (-54.8%), non-GAAP EPS $2.57 (-0.8%)
Revenue $2,402.7M, up 46.8% YoY; proforma constant currency growth of 2.8%.
Concentrix Q4 revenue $2.23B (+36% YoY); GAAP EPS $1.09, non-GAAP EPS $3.36
Q4 revenue $2,230.8M (+36% YoY); GAAP EPS $1.09 (down 46% YoY).
Concentrix Q3 revenue up 3.4% to $1.63B; raises dividend 10% to $0.3025/share
GAAP EPS $1.49 (down 27% YoY); non-GAAP EPS $2.71 (down 8.1%).
Concentrix closes $4B Webhelp acquisition, issues ~14.9M shares and €700M seller note
Transaction valued at ~$4B including net debt; Concentrix paid €488.7M cash, ~14.9M shares, plus up to 750K earnout shares.
Concentrix secures all regulatory approvals for Webhelp combination; close expected Sept 25
All required regulatory approvals obtained for pending Webhelp combination; closing on or about September 25, 2023.
Concentrix shareholders approve Webhelp combination stock issuance
Shareholders approved issuance of 15,611,885 shares for Webhelp combination; 92% voted in favor.
Concentrix issues $2.15B in senior notes to fund Webhelp acquisition, eliminates bridge loan
Issued $800M 6.650% notes due 2026, $800M 6.600% notes due 2028, and $550M 6.850% notes due 2033.
Concentrix prices $2.15B senior notes offering to fund Webhelp acquisition
Priced $800M 6.650% notes due 2026, $800M 6.600% notes due 2028, $550M 6.850% notes due 2033.
FY2022 adj. EBITDA €376.3M (U.S. GAAP); LTM Mar 2023 adj. EBITDA €387.9M ($404.1M).
Concentrix receives demand letters over Webhelp proxy; amends deal structure with restricted shares
Seven stockholder demand letters allege proxy omitted material info on transaction; company says demands are without merit.
Concentrix Q2 revenue up 3% to $1.61B; GAAP EPS $1.51, non-GAAP EPS $2.69
Revenue $1,614.7M (+3% YoY); operating margin 10.1% vs 10.0% a year ago.
Total consideration for Acquired Shares includes €500M cash, Parent common stock issuance, a Sellers' Note, and contingent Earnout Shares.
Concentrix amends credit facility to $3.187B for Webhelp combination financing
Restated Credit Agreement: $1.0425B revolving facility and $2.1447B term loan facility (incl. $294.7M delayed draw).
Concentrix to acquire Webhelp for €1.2B cash/note plus 14.86M shares; $5.29B bridge loan arranged
Total consideration: €500M cash + €700M seller note (2% interest, 2-year) + 14.86M shares + up to 750K earnout shares.
Concentrix to combine with Webhelp in $4.8B deal; creates $9.8B revenue CX leader
Enterprise value $4.8B; expected close by end of 2023 subject to shareholder and regulatory approvals.
Concentrix to acquire Webhelp for ~$4.8B, creating combined CX leader with ~$9.8B pro forma revenue
Transaction valued at ~$4.8B including net debt; Webhelp shareholders receive 14.9M CNXC shares, €500M cash, and €700M note payable at 2%.
Concentrix Q4 revenue $1.64B (+11.9% YoY); GAAP EPS $2.01, non-GAAP $3.01
Q4 revenue $1,640.7M (+11.9% YoY); FY revenue $6,324.5M (+13.2%).
Concentrix Q3 revenue $1.58B (+13.1% YoY); non-GAAP EPS $2.95; dividend raised 10%
Revenue $1,579.6M (+13.1% YoY, +7.5% constant currency); non-GAAP operating margin 14.0% (+100 bps).
Concentrix closes acquisition of ServiceSource to bolster B2B digital sales capabilities
Acquisition of global B2B digital sales company ServiceSource International completed on July 20, 2022.
Concentrix Q2 revenue $1.57B (+14.5% YoY); GAAP EPS $2.14, non-GAAP $2.93
Revenue $1,568.1M (+14.5% YoY); GAAP EPS $2.14 (+36.3%), non-GAAP EPS $2.93 (+23.6%).
Concentrix to acquire ServiceSource for $1.50/share, ~$131M total
All-cash deal valued at ~$131M, including ~$20M net cash; $1.50/share price.
Concentrix Q1 revenue $1.54B, up 13.5% YoY; non-GAAP EPS $2.85, up 24.5%
Revenue $1,536.1M (+13.5% YoY); GAAP diluted EPS $2.09 (+23.7%); Non-GAAP diluted EPS $2.85 (+24.5%).
Bilge Ogut resigned from the Board, including any committees thereof, effective immediately.
On June 3, 2025, Olivier Duha notified the Board of Directors (the “Board”) of Concentrix Corporation (the “Company”) of his decision to resign from the Board, including any committees thereof, effective immediately.
On January 4, 2024, the Board of Directors of Concentrix Corporation (the “Company”) appointed Craig Gibson to the role of Executive Vice President, Global Sales and Account Management, effective immediately.
Mr. Rosso will continue with the Company and transition into a non-executive officer leadership role with the Company for an unspecified period of time prior to his retirement.
Effective as of the closing of the Transaction, on September 25, 2023, Olivier Duha and Nicolas Gheysens were appointed as members of the Company’s Board of Directors
Effective as of the closing of the Transaction, on September 25, 2023, Olivier Duha and Nicolas Gheysens were appointed as members of the Company’s Board of Directors
Mr. Richie departed the Company on October 29, 2021.
Jane C. Fogarty has succeeded Mr. Richie as Executive Vice President, Legal and Corporate Secretary of the Company.
On July 20, 2021, Steven L. Richie, Executive Vice President, Legal and Corporate Secretary of Concentrix Corporation (the “Company” or “Concentrix”) announced his intention to step down from his position at the Company in the fourth fiscal quarter of 2021.
Max materiality 0.95 · Median 0.70 · Most common event earnings